Second phase of cancer awareness campaign launched in Alappuzha
The Health department has launched the second phase of the Arogyam, Anandam - Keep Cancer Away campaign in Alappuzha. It was inaugurated by H. Salam, MLA, in a function held at SD College, Alappuzha, on Thursday.
Officials said the aim of the second phase was to detect and prevent oral cancer and colon cancer in men at an early stage.
The Health department launched the campaign in Alappuzha on World Cancer Day on February 4. The first phase was aimed at strengthening awareness and screening for breast cancer and cervical cancer, which specifically affects women. It targeted women in the 30-65 age group.
The department aims to ensure that as many men as possible undergo screening to facilitate early detection and treatment. Officials said those diagnosed with the disease would receive treatment at Government Medical College Hospital, district/general hospitals, Regional Cancer Centre, Thiruvananthapuram, and so on in accordance with established guidelines.
SD College Principal V.R. Prabhakaran Nair presided. District Medical Officer Jamuna Varghese, Kudumbashree District Mission coordinator S. Renjith and others attended.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
4 days ago
- The Hindu
Second phase of cancer awareness campaign launched in Alappuzha
The Health department has launched the second phase of the Arogyam, Anandam - Keep Cancer Away campaign in Alappuzha. It was inaugurated by H. Salam, MLA, in a function held at SD College, Alappuzha, on Thursday. Officials said the aim of the second phase was to detect and prevent oral cancer and colon cancer in men at an early stage. The Health department launched the campaign in Alappuzha on World Cancer Day on February 4. The first phase was aimed at strengthening awareness and screening for breast cancer and cervical cancer, which specifically affects women. It targeted women in the 30-65 age group. The department aims to ensure that as many men as possible undergo screening to facilitate early detection and treatment. Officials said those diagnosed with the disease would receive treatment at Government Medical College Hospital, district/general hospitals, Regional Cancer Centre, Thiruvananthapuram, and so on in accordance with established guidelines. SD College Principal V.R. Prabhakaran Nair presided. District Medical Officer Jamuna Varghese, Kudumbashree District Mission coordinator S. Renjith and others attended.
Time of India
13-05-2025
- Time of India
Special cancer screening at family health center twice a week for early detection and awareness
T'puram: Health minister Veena George announced that a special cancer screening will be conducted twice a week at the family health centre as part of strengthening the 'Aarogyam Anandam - Akattam Arbudam' public cancer campaign, aimed at cancer prevention, awareness and treatment. Men will also have access to screening facilities, she added. The decision was made at a review meeting on said, "The public should participate in the screening to ensure they are cancer-free or if there is a risk, early treatment can lead to recovery." The minister emphasised the importance of raising awareness to dispel fears and concerns about cancer and to encourage self-detection of cancer the campaign began on World Cancer Day, Feb 4, screenings were conducted for approximately 1.55 million people. Those requiring further tests and treatment were advised accordingly. Currently, 242 individuals were diagnosed with cancer under this campaign, with most cases detected at an early stage, allowing for quicker recovery through treatment, she added."Many cancers can be cured if detected and treated early. In addition to breast and cervical cancers, which primarily affect women, other types of cancer are also screened. Among men, cancers affecting the mouth, rectum, lungs, prostate and liver are more common. Lifestyle changes such as smoking, alcohol consumption, unhealthy eating habits and lack of exercise increase cancer risk in men," she use of tobacco products is a major cause of cancer in the mouth, lungs, oesophagus and stomach. Similarly, alcohol consumption increases the risk of cancer in the liver, oesophagus and mouth. It is important to exercise for at least 30 minutes daily and maintain a healthy weight."Do not ignore unusual changes in the body. If you experience significant weight loss, persistent cough or voice changes, constipation, urinary obstruction or lumps in the body, it is crucial to consult a doctor immediately. Some cancer may not show symptoms in the early stages. Therefore, regular health check-ups at appropriate intervals can help in early detection and treatment. Everyone should participate in screenings at the nearest health centre that offers these facilities," she addition to govt hospitals, private hospitals and labs are also cooperating. Those diagnosed with cancer through the testing will receive treatment and follow-up care. Testing is completely free for those below the poverty line and affordable rates are provided for others.
The Print
10-05-2025
- The Print
Johnson & Johnson Medtech Partners with Qure.ai to Boost Early Detection of Lung Cancer in India
Mumbai (Maharashtra) [India], May 9: Johnson & Johnson MedTech, a global leader in surgical technologies and solutions, has onboarded a global leader in artificial intelligence (AI) for healthcare, as a strategic partner with Johnson & Johnson Private Limited, a Johnson & Johnson company, to enhance early detection of lung cancer in India. This collaboration brings together cutting-edge AI and medical technology, helping identify lung cancer at its most treatable stage. This initiative is part of Project BreatheEZ, a broader strategic collaboration between and Johnson & Johnson MedTech, and designed to establish AI-led Incidental Pulmonary Nodule (IPN) Detection clinics across leading hospitals in India. These clinics will act as integrated screening hubs, optimizing early detection, triaging, and follow-up care for lung cancer patients. As part of this collaboration, AI technology will be deployed across 10 hub medical centers in India, with an additional 20 supporting spoke sites. The first such clinic has been launched in Thangam Cancer Centre in Namakkal, Tamil Nadu. In India, one in nine persons is likely to be diagnosed with cancer in their lifetime. It is an increasing health concern, and the projected cancer burden is expected to rise from 26.7 million DALYs (Disability-Adjusted Life Years) in 2021 to 29.8 million in 2025¹. This growing health challenge needs innovative solutions to improve early detection and ultimately save lives. Traditional diagnostic methods often fail to detect lung cancer at an early stage, leading to delays in treatment. Thus, this collaboration between Johnson & Johnson MedTech and marks a significant leap forward. By harnessing of artificial intelligence in the modalities of X-Ray & CT scans, Johnson & Johnson MedTech India & are enabling the detection of potential lung nodules that might otherwise be missed. This happens through flagging risky nodules in X-Rays and CT Scans that can potentially turn out to be malignant. It also introduces the concept of structured IPN clinics where there is a proactive impetus towards incidental screening of early-stage lung cancer. This partnership embodies Johnson & Johnson MedTech's commitment to enhancing early lung cancer detection, ultimately transforming the standard of lung cancer care. Anuj Virmani, Managing Director, India, Johnson & Johnson MedTech, said, 'Lung cancer continues to be one of the leading causes of cancer in both men and women. In India, where access to advanced healthcare facilities is often limited, especially in tier-2 and tier-3 cities, patients face significant challenges in receiving timely and effective diagnosis, which further delays access to treatment. Our collaboration with is a testament to our commitment to advancing healthcare through innovative solutions continues to drive impactful collaborations and integrating our solutions in lung cancer.' Reference: 1. ICMR and NCDIR World Cancer Day 2024, Close the care gap- Addressing cancer care in India, 04th – February – 2024 Surgical Solutions from Johnson & Johnson MedTech Across Johnson & Johnson, we are tackling the world's most complex and pervasive health challenges. For over 100 years, we have helped advance surgical care through our innovative portfolio across wound closure, adjunctive hemostats, surgical stapling and instruments, robotics and digital solutions. Together, with clinicians and healthcare experts around the world we are progressing what's next in surgery to better solve patient needs in metabolic and cardiovascular disease, cancer, and aesthetics and reconstruction. For more, visit (ADVERTORIAL DISCLAIMER: The above press release has been provided by BusinessWire India. ANI will not be responsible in any way for the content of the same) This story is auto-generated from a syndicated feed. ThePrint holds no responsibility for its content.
